2025 SEOM-SEHAD临床实践共识:肿瘤患者的居家住院治疗

2025-04-23 西班牙肿瘤内科学会 Clinical and Translational Oncology 发表于上海

来自西班牙肿瘤医学学会和西班牙居家住院治疗学会的一组专家召开会议,讨论了对肿瘤患者进行居家复杂照护的最新简要情况,并就临床诊断、收治标准以及对不同类型患者的管理等方面达成了共识。

中文标题:

2025 SEOM-SEHAD临床实践共识:肿瘤患者的居家住院治疗

英文标题:

Hospital at home for oncologic patients: SEOM–SEHAD consensus on clinical practice

发布日期:

2025-04-23

简要介绍:

在全球范围内,肿瘤患者的数量以及生存率都在不断上升。这一情况意味着与癌症及肿瘤治疗相关的共病和并发症会更多。这些并发症中有许多需要患者住院治疗,而由于存在诸如感染、严重功能缺陷或抑郁等医院内因素带来的负担,住院对患者而言又构成了额外的风险因素。此外,住院人数的不断增加意味着全球医疗费用会大幅上升。居家住院(HaH)是一种能让病情失代偿的患者留在家中,由医院的多学科团队进行照护和治疗的模式。而且,与传统的住院治疗相比,居家住院在多种疾病的治疗中已被证明具有显著的成本效益。来自西班牙肿瘤医学学会(SEOM)和西班牙居家住院治疗学会(SEHAD)的一组专家召开会议,讨论了对肿瘤患者进行居家复杂照护的最新简要情况,并就临床诊断、收治标准以及对不同类型患者的管理等方面达成了共识。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2025 SEOM-SEHAD临床实践共识:肿瘤患者的居家住院治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=790361c00a309811, title=2025 SEOM-SEHAD临床实践共识:肿瘤患者的居家住院治疗, enTitle=Hospital at home for oncologic patients: SEOM–SEHAD consensus on clinical practice, guiderFrom=Clinical and Translational Oncology, authorId=0, author=, summary=来自西班牙肿瘤医学学会和西班牙居家住院治疗学会的一组专家召开会议,讨论了对肿瘤患者进行居家复杂照护的最新简要情况,并就临床诊断、收治标准以及对不同类型患者的管理等方面达成了共识。, cover=https://img.medsci.cn/20220906/1662451499353_5552845.jpg, journalId=0, articlesId=null, associationId=2142, associationName=西班牙肿瘤内科学会 , associationIntro=西班牙肿瘤内科学会 (SEOM) , copyright=0, guiderPublishedTime=Wed Apr 23 00:00:00 CST 2025, originalUrl=, linkOutUrl=, content=<p><span style="color: rgba(0, 0, 0, 0.85);">在全球范围内,肿瘤患者的数量以及生存率都在不断上升。这一情况意味着与癌症及肿瘤治疗相关的共病和并发症会更多。这些并发症中有许多需要患者住院治疗,而由于存在诸如感染、严重功能缺陷或抑郁等医院内因素带来的负担,住院对患者而言又构成了额外的风险因素。此外,住院人数的不断增加意味着全球医疗费用会大幅上升。居家住院(HaH)是一种能让病情失代偿的患者留在家中,由医院的多学科团队进行照护和治疗的模式。而且,与传统的住院治疗相比,居家住院在多种疾病的治疗中已被证明具有显著的成本效益。来自西班牙肿瘤医学学会(SEOM)和西班牙居家住院治疗学会(SEHAD)的一组专家召开会议,讨论了对肿瘤患者进行居家复杂照护的最新简要情况,并就临床诊断、收治标准以及对不同类型患者的管理等方面达成了共识。</span></p>, tagList=[TagDto(tagId=504120, tagName=居家住院治疗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100)], articleKeywordId=504120, articleKeyword=居家住院治疗, articleKeywordNum=6, guiderKeywordId=504120, guiderKeyword=居家住院治疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1473, appHits=50, showAppHits=0, pcHits=66, showPcHits=1423, likes=0, shares=18, comments=5, approvalStatus=1, publishedTime=Sun May 04 22:30:00 CST 2025, publishedTimeString=2025-04-23, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=FUNNYMAN, createdTime=Fri May 02 12:13:44 CST 2025, updatedBy=8538692, updatedName=梅斯话题小助手, updatedTime=Thu May 08 11:25:49 CST 2025, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2025 SEOM-SEHAD临床实践共识:肿瘤患者的居家住院治疗.pdf)])
2025 SEOM-SEHAD临床实践共识:肿瘤患者的居家住院治疗.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2263551, encodeId=5b36226355150, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>打卡打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Mon May 05 07:59:13 CST 2025, time=2025-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2263550, encodeId=6c242263550f1, content=阿巴阿巴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Mon May 05 07:59:00 CST 2025, time=2025-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2263541, encodeId=3b962263541d8, content=在全球范围内,肿瘤患者的数量以及生存率都在不断上升, beContent=null, objectType=guider, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Mon May 05 06:08:50 CST 2025, time=2025-05-05, status=1, ipAttribution=内蒙古)]
    2025-05-05 ms3000002106324246 来自四川省

    #PE#打卡打卡

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2263551, encodeId=5b36226355150, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>打卡打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Mon May 05 07:59:13 CST 2025, time=2025-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2263550, encodeId=6c242263550f1, content=阿巴阿巴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Mon May 05 07:59:00 CST 2025, time=2025-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2263541, encodeId=3b962263541d8, content=在全球范围内,肿瘤患者的数量以及生存率都在不断上升, beContent=null, objectType=guider, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Mon May 05 06:08:50 CST 2025, time=2025-05-05, status=1, ipAttribution=内蒙古)]
    2025-05-05 ms3000002106324246 来自四川省

    阿巴阿巴

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2263551, encodeId=5b36226355150, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>打卡打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Mon May 05 07:59:13 CST 2025, time=2025-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2263550, encodeId=6c242263550f1, content=阿巴阿巴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Mon May 05 07:59:00 CST 2025, time=2025-05-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2263541, encodeId=3b962263541d8, content=在全球范围内,肿瘤患者的数量以及生存率都在不断上升, beContent=null, objectType=guider, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Mon May 05 06:08:50 CST 2025, time=2025-05-05, status=1, ipAttribution=内蒙古)]
    2025-05-05 Mongolian 来自内蒙古

    在全球范围内,肿瘤患者的数量以及生存率都在不断上升

    0